Glenmede Trust CO Na Invitae Corp Transaction History

Glenmede Trust CO Na

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$14.7 - $28.67 $289,516 - $564,655	-19,695 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $52,777 - $72,945	-2,171 Reduced 9.93%	19,695 $559,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $23,220 - $35,956	-890 Reduced 3.91%	21,866 $737,000
Q1 2021 May 18, 2021	BUY	$33.06 - $56.93 $15,538 - $26,757	470 Added 2.11%	22,756 $868,000
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $76,772 - $112,733	1,964 Added 9.66%	22,286 $931,000

Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $181,838 - $285,709	6,396 Added 45.93%	20,322 $880,000
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $68,620 - $177,499	5,860 Added 72.65%	13,926 $421,000
Q4 2019 Feb 12, 2020	BUY	$15.02 - $20.57 $34,711 - $47,537	2,311 Added 40.16%	8,066 $130,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $108,481 - $158,262	5,755 New	5,755 $110,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.